These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: An improved method for the routine biochemical evaluation of patients with recurrent calcium oxalate stone disease.
    Author: Tiselius HG.
    Journal: Clin Chim Acta; 1982 Jul 15; 122(3):409-18. PubMed ID: 7105424.
    Abstract:
    By means of a computerized calculation program, a simplified estimate of the ion-activity product of calcium oxalate was derived (AP(CaOx)-index), based on the 24-h urinary excretion of calcium (Ca), oxalate (Ox), magnesium (Mg), citrate (Cit) and the urine volume (V): (formula: see text) With urinary electrolyte values within the normal range, there was a good correlation between the AP(CaOx)-index and the more laboriously obtained ion-activity product (r = 0.997). To express the biochemical risk of CaOx stone formation a CaOx-risk index was designed, which also includes the inhibition of calcium oxalate crystal growth (I) and with all variables related to urinary creatinine (Cr): (formula: see text) The mean CaOx-risk index (+/-SEM) in urine from 100 normal men and 156 male stone formers were 648 +/- 27 and 1019 +/- 38 respectively (p less than 0.001). A risk index without inhibition index, had the corresponding values 366 +/- 14 and 527 +/- 17 (p less than 0.001).
    [Abstract] [Full Text] [Related] [New Search]